Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.

Gupta S, Seshadri MR, Dandekar R, Müller-Jensen L, McCutcheon K, Scarffe LA, Vanasupa SL, Sunahara M, Hayashi F, Caspar C, et al.

medRxiv. 2026 Sep 11. PMID: 42818477. Abstract